Literature DB >> 33262894

New Consensus pattern in Spike CoV-2: potential implications in coagulation process and cell-cell fusion.

Silvia Buonvino1, Sonia Melino1.   

Abstract

Coagulopathy and syncytial formation are relevant effects of the SARS-CoV-2 infection, but the underlying molecular mechanisms triggering these processes are not fully elucidated. Here, we identified a potential consensus pattern in the Spike S glycoprotein present within the cytoplasmic domain; this consensus pattern was detected in only 79 out of 561,000 proteins (UniProt bank). Interestingly, the pattern was present in both human and bat the coronaviruses S proteins, in many proteins involved in coagulation process, cell-cell interaction, protein aggregation and regulation of cell fate, such as von Willebrand factor, coagulation factor X, fibronectin and Notch, characterized by the presence of the cysteine-rich EGF-like domain. This finding may suggest functional similarities between the matched proteins and the CoV-2 S protein, implying a new possible involvement of the S protein in the molecular mechanism that leads to the coagulopathy and cell fusion in COVID-19 disease.
© The Author(s) 2020.

Entities:  

Keywords:  Infectious diseases; Viral proteins

Year:  2020        PMID: 33262894      PMCID: PMC7691694          DOI: 10.1038/s41420-020-00372-1

Source DB:  PubMed          Journal:  Cell Death Discov        ISSN: 2058-7716


  48 in total

1.  Structure-function analysis of the Sendai virus F and HN cytoplasmic domain: different role for the two proteins in the production of virus particle.

Authors:  N Fouillot-Coriou; L Roux
Journal:  Virology       Date:  2000-05-10       Impact factor: 3.616

2.  Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.

Authors:  H Jin; G P Leser; J Zhang; R A Lamb
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 3.  Cell-cell fusion.

Authors:  Elizabeth H Chen; Eric Grote; William Mohler; Agnès Vignery
Journal:  FEBS Lett       Date:  2007-03-21       Impact factor: 4.124

4.  Coronavirus-induced membrane fusion requires the cysteine-rich domain in the spike protein.

Authors:  K W Chang; Y Sheng; J L Gombold
Journal:  Virology       Date:  2000-03-30       Impact factor: 3.616

5.  Fatty acids on the A/USSR/77 influenza virus hemagglutinin facilitate the transition from hemifusion to fusion pore formation.

Authors:  Tatsuya Sakai; Reiko Ohuchi; Masanobu Ohuchi
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles.

Authors:  D A Steinhauer; S A Wharton; J J Skehel; D C Wiley; A J Hay
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

7.  Fatty acids on the A/Japan/305/57 influenza virus hemagglutinin have a role in membrane fusion.

Authors:  C W Naeve; D Williams
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

8.  Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2.

Authors:  A J Venkatakrishnan; Nikhil Kayal; Praveen Anand; Andrew D Badley; George M Church; Venky Soundararajan
Journal:  Cell Death Discov       Date:  2020-10-02

9.  Role of spike protein endodomains in regulating coronavirus entry.

Authors:  Ana Shulla; Tom Gallagher
Journal:  J Biol Chem       Date:  2009-09-30       Impact factor: 5.157

10.  COVID-19 infection: mitohormetic concept of immune response.

Authors:  Jerzy Gebicki; Marzena Wieczorkowska
Journal:  Cell Death Discov       Date:  2020-07-14
View more
  9 in total

1.  Furin and the adaptive mutation of SARS-COV2: a computational framework.

Authors:  Ayesha Sohail; Sümeyye Tunc; Alessandro Nutini; Robia Arif
Journal:  Model Earth Syst Environ       Date:  2021-08-26

Review 2.  Immune response in COVID-19: what is next?

Authors:  Qing Li; Ying Wang; Qiang Sun; Jasmin Knopf; Martin Herrmann; Liangyu Lin; Jingting Jiang; Changshun Shao; Peishan Li; Xiaozhou He; Fei Hua; Zubiao Niu; Chaobing Ma; Yichao Zhu; Giuseppe Ippolito; Mauro Piacentini; Jerome Estaquier; Sonia Melino; Felix Daniel Weiss; Emanuele Andreano; Eicke Latz; Joachim L Schultze; Rino Rappuoli; Alberto Mantovani; Tak Wah Mak; Gerry Melino; Yufang Shi
Journal:  Cell Death Differ       Date:  2022-05-17       Impact factor: 12.067

3.  COVID-19: the CaMKII-like system of S protein drives membrane fusion and induces syncytial multinucleated giant cells.

Authors:  Liu Wenzhong; Li Hualan
Journal:  Immunol Res       Date:  2021-08-19       Impact factor: 2.829

4.  Effect of mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion function.

Authors:  Chelsea T Barrett; Hadley E Neal; Kearstin Edmonds; Carole L Moncman; Rachel Thompson; Jean M Branttie; Kerri Beth Boggs; Cheng-Yu Wu; Daisy W Leung; Rebecca E Dutch
Journal:  bioRxiv       Date:  2021-01-25

Review 5.  Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19.

Authors:  Shama Ahmad; Shajer Manzoor; Simmone Siddiqui; Nithya Mariappan; Iram Zafar; Aamir Ahmad; Aftab Ahmad
Journal:  Semin Cancer Biol       Date:  2021-01-20       Impact factor: 17.012

6.  Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development.

Authors:  Aleksandra Gruca; Joanna Ziemska-Legiecka; Patryk Jarnot; Elzbieta Sarnowska; Tomasz J Sarnowski; Marcin Grynberg
Journal:  BMC Bioinformatics       Date:  2021-04-08       Impact factor: 3.169

7.  Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis.

Authors:  Roberta Nardacci; Francesca Colavita; Concetta Castilletti; Daniele Lapa; Giulia Matusali; Silvia Meschi; Franca Del Nonno; Daniele Colombo; Maria Rosaria Capobianchi; Alimuddin Zumla; Giuseppe Ippolito; Mauro Piacentini; Laura Falasca
Journal:  Cell Death Dis       Date:  2021-03-12       Impact factor: 8.469

8.  Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system.

Authors:  Mohamad Ammar Ayass; Wanying Cao; Jin Zhang; Jun Dai; Kevin Zhu; Trivendra Tripathi; Natalya Griko; Victor Pashkov; Lina Abi-Mosleh
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

9.  Low level of plasminogen increases risk for mortality in COVID-19 patients.

Authors:  David Della-Morte; Francesca Pacifici; Camillo Ricordi; Renato Massoud; Valentina Rovella; Stefania Proietti; Mariannina Iozzo; Davide Lauro; Sergio Bernardini; Stefano Bonassi; Nicola Di Daniele
Journal:  Cell Death Dis       Date:  2021-08-05       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.